|

RBNZ: Clearly dovish, NZD to come under pressure – ANZ

The Reserve Bank of New Zealand (RBNZ) increased their quantitative easing (LSAP) programme to NZD 100 billion and extended its length from 12 to 22 months. As regards potential alternative policy options beyond the LSAP, the RBNZ expressed a preference for a lower or negative OCR and a ‘Funding for Lending Programme’, while leaving all options on the table. The OCR will remain unchanged at 0.25% until March 2021 but the odds of lower rates beyond that have risen. Yields and the NZD both fell in response, per ANZ Bank.

Key quotes

“The RBNZ’s LSAP programme was scaled up from NZD 60 billion to NZD 100 billion, even more than we were expecting. This was based on ‘updated staff advice that central bank purchases could absorb a larger proportion of the total market than previously thought without affecting market functioning.’ In addition, ‘Members noted and endorsed staff advice that a larger LSAP programme would mean purchases could be front-loaded in order to put more downward pressure on New Zealand wholesale interest rates’.” 

“The RBNZ reiterated that the OCR would remain unchanged at 0.25% until at least March 2021, but gave no forecasts after that.”

“It’s difficult to imagine a more dovish outcome than what we have seen. This speaks to the whole term structure of interest rates going lower, with the prospect of negative rates driving the short end lower, and the larger than expected LSAP driving the long end lower. Against the global backdrop of inflation fears, we expect NZGBs to outperform global peers, and for the NZD to be under significant pressure over coming weeks.” 

“The NZD moved 30-40bps lower immediately, but has since recovered part of the move. Given how dovish the tone was, we see a real risk that the NZD weakens further in coming weeks as the gravity of today sinks in.”

Author

More from FXStreet Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.